Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody ...
Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license ...
Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI blocking antibody ...
Epstein-Barr virus antibodies could help differentiate MS from MOGAD and NMOSD. Discover how this biomarker may improve ...
Peptide conjugation techniques are advancing CNS delivery of oligonucleotides, addressing blood-brain barrier challenges and ...
The oversubscribed round will support final assay development and manufacturing readiness for an early access program launch.
How does the gut cause Multiple Sclerosis? New research identifies the MHC II protein in intestinal epithelial cells as the trigger for MS-related neuroinflammation. Discover how gut-primed T cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results